CORZIDE is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is Nadolol; Bendroflumethiazide.
Product ID | 60793-284_634fa33e-798d-49ac-b968-9e8b48fa7239 |
NDC | 60793-284 |
Product Type | Human Prescription Drug |
Proprietary Name | CORZIDE |
Generic Name | Nadolol And Bendroflumethiazide |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 1983-05-25 |
Marketing End Date | 2019-10-31 |
Marketing Category | NDA / NDA |
Application Number | NDA018647 |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | NADOLOL; BENDROFLUMETHIAZIDE |
Active Ingredient Strength | 80 mg/1; mg/1 |
Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Marketing Start Date | 1983-05-25 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA018647 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1983-05-25 |
Marketing End Date | 2019-10-31 |
Ingredient | Strength |
---|---|
NADOLOL | 80 mg/1 |
SPL SET ID: | 3f11df27-710b-4903-a985-74ee4674a844 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
60793-283 | CORZIDE | nadolol and bendroflumethiazide |
60793-284 | CORZIDE | nadolol and bendroflumethiazide |
0115-5311 | Nadolol and Bendroflumethiazide | NADOLOL and BENDROFLUMETHIAZIDE |
0115-5322 | Nadolol and Bendroflumethiazide | NADOLOL and BENDROFLUMETHIAZIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CORZIDE 73256143 1170890 Live/Registered |
E. R. Squibb & Sons Inc. 1980-03-31 |